Cite
Phase II trial of fenretinide in advanced renal carcinoma
MLA
Ralph E. Parchment, et al. “Phase II Trial of Fenretinide in Advanced Renal Carcinoma.” Investigational New Drugs, vol. 23, Jan. 2005, pp. 179–85. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....70763b7099c4d011c3d60abd3a282bde&authtype=sso&custid=ns315887.
APA
Ralph E. Parchment, Ramesh R. Boinpally, Maha Hussain, Ulka N. Vaishampayan, Lance K. Heilbrun, James A. Zwiebel, Patricia LoRusso, & Vikash Jain. (2005). Phase II trial of fenretinide in advanced renal carcinoma. Investigational New Drugs, 23, 179–185.
Chicago
Ralph E. Parchment, Ramesh R. Boinpally, Maha Hussain, Ulka N. Vaishampayan, Lance K. Heilbrun, James A. Zwiebel, Patricia LoRusso, and Vikash Jain. 2005. “Phase II Trial of Fenretinide in Advanced Renal Carcinoma.” Investigational New Drugs 23 (January): 179–85. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....70763b7099c4d011c3d60abd3a282bde&authtype=sso&custid=ns315887.